Sugi Predict

Sugi Predict / Compounds / SCHEMBL4574604

SCHEMBL4574604

SCHEMBL4574604

ClCc1nc(C2(c3ccc(Cl)cc3)CC2)no1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.42
▸ MEN1 O00255 5/20 0.42
▸ LMNA P02545 2/20 0.41
▸ RBP1 P09455 3/20 0.40
▸ ALDH1A1 P00352 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ HTT P42858 2/20 0.38
▸ ALOX5AP P20292 2/20 0.36
▸ NOTUM Q6P988 2/20 0.36
▸ CCNB2 O95067 1/20 0.35
▸ CDK1 P06493 1/20 0.35
▸ CCNB1 P14635 1/20 0.35
▸ GSK3B P49841 1/20 0.35
▸ CDK5 Q00535 1/20 0.35
▸ CDK5R1 Q15078 1/20 0.35
▸ CCNB3 Q8WWL7 1/20 0.35
▸ BACE1 P56817 1/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4574917 0.94 KMT2A (0.46) KMT2AMEN1LMNARBP1ALDH1A1
SCHEMBL4746729 0.92 KMT2A (0.40) KMT2AMEN1LMNARBP1ALDH1A1
SCHEMBL4574278 0.87 KMT2A (0.41) KMT2AMEN1LMNARBP1ALDH1A1
SCHEMBL4575272 0.87 KMT2A (0.55) KMT2AMEN1LMNARBP1ALDH1A1
SCHEMBL8223460 0.86 RBP1 (0.40) KMT2AMEN1LMNARBP1ALDH1A1
SCHEMBL23588214 0.83 SLC6A4 (0.38) KMT2AMEN1LMNARBP1ALDH1A1
SCHEMBL29844350 0.83 SLC6A4 (0.38) KMT2AMEN1LMNARBP1ALDH1A1
SCHEMBL4574617 0.81 KMT2A (0.62) KMT2AMEN1LMNARBP1ALDH1A1
SCHEMBL16629560 0.81 KMT2A (0.47) KMT2AMEN1LMNARBP1ALDH1A1
SCHEMBL4574830 0.81 KMT2A (0.47) KMT2AMEN1LMNARBP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219907-A1 CARBOXY DERIVATIVES WITH ANTIINFLAMATORY PROPERTIES SITRYX THERAPEUTICS LIMITED (GB) 2023-07-13 — — US disclosed
US-20230219907-A1 CARBOXY DERIVATIVES WITH ANTIINFLAMATORY PROPERTIES SITRYX THERAPEUTICS LIMITED (GB) 2023-07-13 — — US disclosed
EP-4081511-A1 CARBOXY DERIVATIVES WITH ANTIINFLAMMATORY PROPERTIES Sitryx Therapeutics Limited (GB) 2022-11-02 — — EP disclosed
CN-115066418-A Carboxy derivatives with anti-inflammatory properties 西特瑞治疗有限公司 2022-09-16 — — CN disclosed
WO-2021130492-A1 CARBOXY DERIVATIVES WITH ANTIINFLAMMATORY PROPERTIES SITRYX THERAPEUTICS LIMITED (GB) 2021-07-01 — — WO disclosed
WO-2008050200-A1 OXADIAZOLE COMPOUNDS AS CALCIUM CHANNEL ANTAGONISTS PFIZER PRODUCTS INC. (US) 2008-05-02 — — WO disclosed
WO-2008050200-A1 OXADIAZOLE COMPOUNDS AS CALCIUM CHANNEL ANTAGONISTS PFIZER PRODUCTS INC. (US) 2008-05-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219907-A1 CARBOXY DERIVATIVES WITH ANTIINFLAMATORY PROPERTIES CPA2, RO60, C5AR1 KMT2A 3125/4885MEN1 4504/4885LMNA 3388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.